Precys Launches to Guide Med-Tech Companies and Investors in the Development and Delivery of Innovative Medical Devices
Medical device industry leader Anthony Arnold today announced the launch of Precys, a med-tech consulting firm that will serve investors and companies of all sizes working to commercialize innovative medical technologies designed to improve patient outcomes and reduce the cost burden on our healthcare system.
Leveraging Arnold’s experience from a range of leading med-tech companies including Boston Scientific, Medtronic and SetPoint Medical and his broad network of collaborators across the med-tech industry, Precys (pronounced precise) provides strategic assistance to startups, venture investors, companies pursuing a bioelectronic device strategy and companies developing novel patient administered bioelectronic and neuromodulation applications across a range of therapeutic targets.
“From evaluating the engineering behind new therapies to advising on commercialization strategy to interim C-level support and assistance with fundraising, we are excited to help innovative medical technology companies succeed and ultimately make a difference for patients and for our healthcare system,” said Anthony Arnold, Precys CEO and founder.
Precys, based in Santa Clarita, CA, delivers insights, expertise and connections to assist companies and investors that are commercializing innovative medical devices. Precys was founded by med-tech industry veteran and bioelectronic medicine pioneer Anthony Arnold, previously CEO of SetPoint Medical, the first company to conduct human clinical trials with an implanted bioelectronic therapy. Arnold has more than 25 years of medical device industry experience, including leadership positions at Advanced Bionics, Boston Scientific, Medtronic, Setpoint Medical and Smith+Nephew. To contact Precys: www.precys.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190117005521/en/